Brexpiprazole is an atypical antipsychotic used in the treatment of schizophrenia and major depressive disorders. Brexpiprazole has been associated with a low rate of serum aminotransferase elevations during therapy, but has not been linked to instances of clinically apparent acute liver injury. Karpschem reference standards serves as basis for evaluation of both process and product performance and serves […]
Teneligliptin Impurities Now Available Ready Stock in KarpsChem
Teneligliptin hydrobromide hydrate was approved by Pharmaceuticals and Medicals Devices Agency of Japan (PMDA) on June 29, 2012. It was co-developed & co-marketed as Tenelia® by Mitsubishi Tanabe and Daiichi Sankyo. Teneligliptin hydrobromide hydrate is a dipeptidyl peptidase-4 inhibitor. It is indicated for the treatment of type 2 diabetes. Tenelia® is available as tablet for oral use, […]
KarpsChem Recent Impurity Development Update: October
Variety of impurities like Genotoxic, Neurotoxic impurities required for agencies like USFDA, MHRDA etc,are available. KarpsChem specialized in manufacturing and supply of pharmacopoeia impurities, process impurities, isolation and identification of unknown impurities. KarpsChem is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Guaifenesin, pharmacopeial and non-pharmacopeial Guaifenesin impurities, metabolites, stable […]